Answers to the European Commission on the ... - Eiopa - Europa
Answers to the European Commission on the ... - Eiopa - Europa
Answers to the European Commission on the ... - Eiopa - Europa
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
liability. The precise treatment of opti<strong>on</strong> take-up rates within best<br />
estimate cash flows, insurance liabilities and <str<strong>on</strong>g>the</str<strong>on</strong>g> SCR will need fur<str<strong>on</strong>g>the</str<strong>on</strong>g>r<br />
c<strong>on</strong>siderati<strong>on</strong>.<br />
Profits at incepti<strong>on</strong><br />
7.17 Valuing insurance liabilities by using <str<strong>on</strong>g>the</str<strong>on</strong>g> best estimate approach may<br />
lead <str<strong>on</strong>g>to</str<strong>on</strong>g> <str<strong>on</strong>g>the</str<strong>on</strong>g> recogniti<strong>on</strong> of profits or losses at incepti<strong>on</strong> of an insurance<br />
c<strong>on</strong>tract. On this issue, it is stated in <str<strong>on</strong>g>the</str<strong>on</strong>g> Basis for c<strong>on</strong>clusi<strong>on</strong>s IFRS 4 16<br />
that:<br />
"Assets and liabilities arising from insurance c<strong>on</strong>tracts should be<br />
measured at fair value. In <str<strong>on</strong>g>the</str<strong>on</strong>g> absence of market evidence <str<strong>on</strong>g>to</str<strong>on</strong>g> <str<strong>on</strong>g>the</str<strong>on</strong>g><br />
c<strong>on</strong>trary, <str<strong>on</strong>g>the</str<strong>on</strong>g> estimated value of an insurance liability shall not be less,<br />
but may be more, than <str<strong>on</strong>g>the</str<strong>on</strong>g> entity would charge <str<strong>on</strong>g>to</str<strong>on</strong>g> accept new c<strong>on</strong>tracts<br />
with identical c<strong>on</strong>tractual terms and remaining maturity from new<br />
policy holders. It follows that an insurer would not recognise a net gain<br />
at incepti<strong>on</strong> of an insurance c<strong>on</strong>tract, unless such market evidence is<br />
available."<br />
7.18 For with-profit c<strong>on</strong>tracts and in a number of o<str<strong>on</strong>g>the</str<strong>on</strong>g>r cases, any surplus at<br />
incepti<strong>on</strong> might not be recognised as profit because of requirements in<br />
nati<strong>on</strong>al law <str<strong>on</strong>g>to</str<strong>on</strong>g> distribute surplus <str<strong>on</strong>g>to</str<strong>on</strong>g> policyholders. In <str<strong>on</strong>g>the</str<strong>on</strong>g>se cases,<br />
calculating <str<strong>on</strong>g>the</str<strong>on</strong>g> best estimate of guaranteed benefits may lead <str<strong>on</strong>g>to</str<strong>on</strong>g> a<br />
number of practical difficulties. A pragmatic approach might be <str<strong>on</strong>g>to</str<strong>on</strong>g> value<br />
<str<strong>on</strong>g>the</str<strong>on</strong>g> c<strong>on</strong>tract <strong>on</strong> a tariff basis at incepti<strong>on</strong>, although valuati<strong>on</strong> postincepti<strong>on</strong><br />
would require fur<str<strong>on</strong>g>the</str<strong>on</strong>g>r c<strong>on</strong>siderati<strong>on</strong>.<br />
7.19 Alternatively, any difference between <str<strong>on</strong>g>the</str<strong>on</strong>g> fair value of a policy and <str<strong>on</strong>g>the</str<strong>on</strong>g><br />
valuati<strong>on</strong> of a policy based <strong>on</strong> guaranteed benefits discounted using a<br />
risk-free interest rate could be interpreted as a technical provisi<strong>on</strong><br />
corresp<strong>on</strong>ding <str<strong>on</strong>g>to</str<strong>on</strong>g> future or potential b<strong>on</strong>us, ra<str<strong>on</strong>g>the</str<strong>on</strong>g>r than as 'profit'.<br />
Segmentati<strong>on</strong><br />
7.20 Assessing <str<strong>on</strong>g>the</str<strong>on</strong>g> probability distributi<strong>on</strong>s of future cash flows requires a<br />
classificati<strong>on</strong> of underwriting risks in<str<strong>on</strong>g>to</str<strong>on</strong>g> groups with similar<br />
characteristics, known as homogenous risk groups. This classificati<strong>on</strong><br />
must be based in part <strong>on</strong> informati<strong>on</strong> from his<str<strong>on</strong>g>to</str<strong>on</strong>g>rical data <strong>on</strong> <str<strong>on</strong>g>the</str<strong>on</strong>g><br />
liabilities portfolio, <str<strong>on</strong>g>the</str<strong>on</strong>g> undertaking’s specific circumstances and<br />
relevant data from <str<strong>on</strong>g>the</str<strong>on</strong>g> insurance industry.<br />
7.21 C<strong>on</strong>ceptually, <str<strong>on</strong>g>the</str<strong>on</strong>g> risk margin related <str<strong>on</strong>g>to</str<strong>on</strong>g> <str<strong>on</strong>g>the</str<strong>on</strong>g> quantitative level of<br />
prudence should be calculated at <str<strong>on</strong>g>the</str<strong>on</strong>g> level of <str<strong>on</strong>g>the</str<strong>on</strong>g> insurance undertaking<br />
as a whole. However, in practice, a valuati<strong>on</strong> of liabilities will require a<br />
classificati<strong>on</strong> of underwriting risks in<str<strong>on</strong>g>to</str<strong>on</strong>g> homogenous risk groups.<br />
CEIOPS would need <str<strong>on</strong>g>to</str<strong>on</strong>g> assess whe<str<strong>on</strong>g>the</str<strong>on</strong>g>r <str<strong>on</strong>g>the</str<strong>on</strong>g>se homogenous risk groups<br />
might vary from nati<strong>on</strong>al market <str<strong>on</strong>g>to</str<strong>on</strong>g> nati<strong>on</strong>al market, according <str<strong>on</strong>g>to</str<strong>on</strong>g><br />
criteria defined at EU level.<br />
16 IASB (2004) – Basis for c<strong>on</strong>clusi<strong>on</strong>s <strong>on</strong> IFRS 4 Insurance C<strong>on</strong>tracts.<br />
14